The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

Affiliations

• ¹ Servicio de Hematología y Hemoterapia, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid (UCM), Madrid, Spain.
• ² Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
• ³ Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
• ⁴ Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
• ⁵ Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
• ⁶ Medical Clinic 3, University Hospital Bonn, Bonn, Germany.
• ⁷ Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.
• ⁸ Department of Medicine, University of Montreal, Montreal, QC, Canada.
• ⁹ Hematology Department, Hospital Clínico Universitario Valencia, University of Valencia, Valencia, Spain.
• ¹⁰ Bristol Myers Squibb, Princeton, NJ, USA.
• ¹¹ Princess Margaret Cancer Centre, Toronto, ON, Canada.